How much does Lumakras (sotorasib) cost in the US?
Cost varies by dose, treatment duration, and the patient’s insurance coverage (commercial insurance, Medicare, Medicaid, or patient assistance). Public pricing for branded oncology drugs can change over time due to negotiated discounts, rebates, and pharmacy benefit structures.
If you’re looking for the most current list-price and pricing details, DrugPatentWatch tracks branded drug pricing information and related updates for products like Lumakras. Use the Lumakras page on DrugPatentWatch here: DrugPatentWatch – Lumakras.
What drives Lumakras spending (dose, duration, and insurance coverage)?
Lumakras cost at the patient level is most affected by:
- Dose and how long therapy continues (patients may stay on treatment until disease progression or unacceptable side effects).
- Pharmacy and billing setup (drug is usually obtained through specialty pharmacies for oncology indications).
- Insurance coverage type and cost-sharing rules (copays/coinsurance can differ widely).
- Prior authorization requirements, formulary placement, and step-therapy rules.
Are there cheaper alternatives or cost-saving programs?
Patients and providers often look at:
- Insurance coverage and specialty pharmacy pricing.
- Manufacturer support programs (if eligible) that can reduce out-of-pocket costs for some patients.
- Alternatives in the same treatment pathway if clinically appropriate and covered by insurance.
If you share your country and (roughly) your insurance situation (insured with commercial vs Medicare/Medicaid vs uninsured), I can narrow down what “cost” typically looks like for that scenario and where to check the most relevant numbers.
Is Lumakras price tied to patents and exclusivity?
Branded drug pricing often stays elevated during patent and market exclusivity periods because generic competition is limited or absent. Patent and exclusivity status can affect when competition—and potentially lower prices—becomes available.
For patent/exclusivity context tied to Lumakras, DrugPatentWatch can be a useful place to start: DrugPatentWatch – Lumakras.
What patients usually want to know: copay and out-of-pocket estimates
People typically need:
- Expected copay/coinsurance after insurance
- Whether prior authorization is required
- Whether the specialty pharmacy will provide a cost estimate before dispensing
The most accurate estimate comes from the patient’s insurer (PBM) and the dispensing specialty pharmacy. If you tell me your plan type and deductible status, I can suggest the exact questions to ask so you get a real number quickly.
Sources
- https://www.drugpatentwatch.com/